Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Identification and characterization of collagen XXIII alpha 1 as a novel risk factor for eczema herpeticum

View ORCID ProfileShruti Chopra, View ORCID ProfileLennart M. Roesner, View ORCID ProfileKatinka Döhner, View ORCID ProfileJana Zeitvogel, View ORCID ProfileStephan Traidl, View ORCID ProfileElke Rodriguez, View ORCID ProfileInken Harder, View ORCID ProfileWolfgang Lieb, View ORCID ProfileStephan Weidinger, View ORCID ProfileThomas F. Schulz, View ORCID ProfileBeate Sodeik, View ORCID ProfileThomas Werfel
doi: https://doi.org/10.1101/2024.07.13.24310236
Shruti Chopra
1Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Shruti Chopra
  • For correspondence: chopra.shruti{at}mh-hannover.de
Lennart M. Roesner
1Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany
2Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lennart M. Roesner
Katinka Döhner
1Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Katinka Döhner
Jana Zeitvogel
1Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jana Zeitvogel
Stephan Traidl
1Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stephan Traidl
Elke Rodriguez
3Department of Dermatology, Venereology, and Allergology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
4Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Elke Rodriguez
Inken Harder
3Department of Dermatology, Venereology, and Allergology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Inken Harder
Wolfgang Lieb
5Institute of Epidemiology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Wolfgang Lieb
Stephan Weidinger
3Department of Dermatology, Venereology, and Allergology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stephan Weidinger
Thomas F. Schulz
2Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, Hannover, Germany
6Institute of Virology, Hannover Medical School, Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thomas F. Schulz
Beate Sodeik
2Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, Hannover, Germany
6Institute of Virology, Hannover Medical School, Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Beate Sodeik
Thomas Werfel
1Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany
2Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thomas Werfel
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Eczema herpeticum (EH) is a potentially life-threatening disseminated skin infection caused by herpes simplex virus (HSV) in a subset of patients with atopic dermatitis (AD). Genetic factors play a pivotal role in EH development. Herein, we identify a single nucleotide polymorphism (SNP) rs2973744 in the gene encoding collagen XXIII alpha 1 chain (Col23a1) as a novel genetic risk factor for EH using whole exome sequencing. EH-patient-derived primary keratinocytes carrying the SNP rs2973744 show elevated COL23A1 mRNA and total protein levels as well as increased susceptibility to HSV-1. We discover that increasing Col23a1 levels enhances HSV-1 infection in human keratinocytes. The transcriptomic analysis unveils that COL23A1 overexpression dampens keratinocyte immune responses, thereby elucidating the molecular mechanism underlying exacerbated HSV-1 susceptibility. Our findings report a novel potential screening marker and therapeutic target for EH and reveal Col23a1’s unexplored role in HSV-1 pathogenesis.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was funded by EXNet-0030-Phase2-3 Communities allied in infection (COALITION) and by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germanys Excellence Strategy-EXC 2155 RESIST- project ID 39087428.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The ethics committee of Hannover Medical School (No. 8733_BO_S_2019) approved this study and all study participants provided written informed consent. DNA samples from AD patients with and without a history of EH were derived from the GENEVA cohort, Biobank of the University Hospital Schleswig-Holstein (UKSH), Kiel, Germany.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Footnotes

  • Abstract was re-written and the author contributions were added. The funding statement, acknowledgements and references were updated. The figure legends were updated and the colors in all the figures were changed. The protein name for collagen XXIII alpha 1 chain is denoted by Col23a1.

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

  • Abbreviations

    AD
    atopic dermatitis
    ADEH+
    AD patients with a history of eczema herpeticum
    ADEH-
    AD patients without a history of eczema herpeticum
    Che
    mCherry
    Col23a1
    collagen type XXIII alpha 1 chain
    E
    early HSV-1 gene
    EH
    eczema herpeticum
    FI
    furin inhibitor I
    GFP
    green fluorescent protein
    GO
    Gene Ontology
    Hpi
    hours post-infection
    HSV-1
    herpes simplex virus type 1
    IE
    immediate-early HSV-1 gene
    L
    late HSV-1 gene
    MARCO
    macrophage receptor with collagenous structure
    MOI
    multiplicity of infection
    mRNA
    messenger RNA
    PCR
    polymerase chain reaction
    Pfu
    plaque-forming unit
    qPCR
    quantitative PCR
    RNA-seq
    RNA sequencing
    RT-PCR
    reverse transcription PCR
    RT-qPCR
    quantitative RT-PCR
    SD
    standard deviation
    SNP
    single nucleotide polymorphism
    WT
    wild type.
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted July 19, 2024.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Identification and characterization of collagen XXIII alpha 1 as a novel risk factor for eczema herpeticum
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Identification and characterization of collagen XXIII alpha 1 as a novel risk factor for eczema herpeticum
    Shruti Chopra, Lennart M. Roesner, Katinka Döhner, Jana Zeitvogel, Stephan Traidl, Elke Rodriguez, Inken Harder, Wolfgang Lieb, Stephan Weidinger, Thomas F. Schulz, Beate Sodeik, Thomas Werfel
    medRxiv 2024.07.13.24310236; doi: https://doi.org/10.1101/2024.07.13.24310236
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Identification and characterization of collagen XXIII alpha 1 as a novel risk factor for eczema herpeticum
    Shruti Chopra, Lennart M. Roesner, Katinka Döhner, Jana Zeitvogel, Stephan Traidl, Elke Rodriguez, Inken Harder, Wolfgang Lieb, Stephan Weidinger, Thomas F. Schulz, Beate Sodeik, Thomas Werfel
    medRxiv 2024.07.13.24310236; doi: https://doi.org/10.1101/2024.07.13.24310236

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Dermatology
    Subject Areas
    All Articles
    • Addiction Medicine (349)
    • Allergy and Immunology (668)
    • Allergy and Immunology (668)
    • Anesthesia (181)
    • Cardiovascular Medicine (2648)
    • Dentistry and Oral Medicine (316)
    • Dermatology (223)
    • Emergency Medicine (399)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
    • Epidemiology (12228)
    • Forensic Medicine (10)
    • Gastroenterology (759)
    • Genetic and Genomic Medicine (4103)
    • Geriatric Medicine (387)
    • Health Economics (680)
    • Health Informatics (2657)
    • Health Policy (1005)
    • Health Systems and Quality Improvement (985)
    • Hematology (363)
    • HIV/AIDS (851)
    • Infectious Diseases (except HIV/AIDS) (13695)
    • Intensive Care and Critical Care Medicine (797)
    • Medical Education (399)
    • Medical Ethics (109)
    • Nephrology (436)
    • Neurology (3882)
    • Nursing (209)
    • Nutrition (577)
    • Obstetrics and Gynecology (739)
    • Occupational and Environmental Health (695)
    • Oncology (2030)
    • Ophthalmology (585)
    • Orthopedics (240)
    • Otolaryngology (306)
    • Pain Medicine (250)
    • Palliative Medicine (75)
    • Pathology (473)
    • Pediatrics (1115)
    • Pharmacology and Therapeutics (466)
    • Primary Care Research (452)
    • Psychiatry and Clinical Psychology (3432)
    • Public and Global Health (6527)
    • Radiology and Imaging (1403)
    • Rehabilitation Medicine and Physical Therapy (814)
    • Respiratory Medicine (871)
    • Rheumatology (409)
    • Sexual and Reproductive Health (410)
    • Sports Medicine (342)
    • Surgery (448)
    • Toxicology (53)
    • Transplantation (185)
    • Urology (165)